AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Advancements in CLL Treatment
This chapter explores the evolving landscape of Chronic Lymphocytic Leukemia (CLL) therapies, particularly focusing on the impact of BTK inhibitors and the comparison of obinutuzumab versus rituximab. It highlights the significance of recent trials, treatment duration, and the role of venetoclax, while addressing patient-specific considerations in treatment choices.